Cancer Education and Research Institute
Worldwide Access to High-Quality Care, Research, and Education

United Nations, UNIATF Award 2019 Recipient

DONATE to support our programs
  • Home
    • About us >
      • About the Founder
    • Annual Reports and Media Kit
    • News Room >
      • CERI Press Releases 2022
      • CERI Press Releases 2021
      • Press Releases 2020
      • Press Releases 2019
      • Press Releases 2018
      • Press Releases 2017
      • Press Releases 2016
      • Press Releases 2015
      • Press Releases 2014
      • Press Releases 2013
    • Testimonials
  • MULTI-LANGUAGE CANCER BLOG
  • For Patients
    • CERI Personalized Patient Program™
    • All about cancer
    • Cancer Education
    • Watch Our Cancer Videos >
      • Ovarian cancer diagnosis
    • Our Publications >
      • Read CERI Simplified Cancer Research Articles
    • Cancer Types
    • Cancer detection and cancer treatment
    • Cancer Awareness Months
  • Events
  • Donate
    • Sponsorship levels
    • Membership
    • Become A Sponsor
    • Shop at CERI
    • Volunteer
    • Become a CERI Board Member
  • Contact us

Cancer News


Cancer Education and Research Institute® (CERI)'s Cancer Education Programs 

Our Team of cancer experts at Cancer Education and Research Institute® (CERI)'s, formerly Cancer Research Simplified, provides you with the most reliable, most up-to-date, and simplified cancer information available. Our educational programs quickly became trusted and highly sought after worldwide.  

CERI strongly stands behind the importance of cancer patient empowerment and is a worldwide leading source for simplified, multi-language cancer education.  Knowledge is power and empowerment is the key for greater treatment success, early diagnosis, as well as cancer prevention.  

For any questions or requests, please submit your inquiry at our CERI Personalized Patient Program™ page.
Tweet
Follow @canceredinst

New Research - Glioblastoma Treatment


Researchers have discovered a novel approach to successfully treat the fatal brain cancer - Glioblastoma.

Aygün Sahin, MSc, PhD  | CEO, President, and Cancer Lead, Cancer Education and Research Institute (CERI)
Picture
What is Gliobastoma multiforme (Glioblastoma)?

Glioblastoma is the most invasive, aggressive, and deadly form of adult brain cancer. Current treatment involves surgery, chemotherapy, and radiotherapy. Despite these therapies, not only that it often comes back, the lifespan of a treated patient is less than 12 months.

New research: Combo therapy with Viruses and Immunotherapy

A two-phase clinical trial was conducted by an international team of researchers, which included Drs. Farshad Nassiri and Gelareh Zadeh from the University Health Network (UHN) in Toronto, resulted in the discovery of a novel approach for the successful treatment of fatal brain cancer.

The treatment follows a two-step process and has displayed positive outcomes in a two-phase clinical trial. 

STEP 1: The initial step involves the doctors administering an "oncolytic" virus straight into the tumor, which has a specific task- targeting and eliminating cancer cells.

STEP 2: The second step involved intravenous immunotherapy, with patients receiving an anti-PD-1 antibody designed to prevent cancer from evading the immune system. The outcomes have been promising, offering hope for those affected by this devastating disease.

Picture
Picture
The results of this breakthrough approach have shown prolonged survival rates and complete eradication of tumors.
By combining oncolytic virus and immunotherapy, researchers found that the treatment was safe and well-tolerated, and not only led to improved patient survival rates for 12.5 months but also resulted in some tumors shrinking or disappearing completely. This was particularly remarkable as the patients in the trial did not undergo tumor resection, receiving only the virus injection. This marks a new treatment approach for glioblastoma.
​
Picture
An additional Genetic Discovery
In addition to these promising results, the researchers also discovered a new genetic signature within tumor samples. They believe that this new genetic signature could help predict which patients are most likely to respond to the treatment.
Picture
Picture
The next steps
The researchers aim to conduct a randomized clinical trial to compare the effectiveness of the combination therapy with other treatments, taking their findings to the next level.
​
Picture
Summary
The promising results of the study provide a significant advancement in the treatment of glioblastoma, a highly aggressive and deadly form of adult brain cancer.

​The innovative method and identification of a new genetic marker have the potential to lead to more individualized therapies in the future, bringing optimism to those affected by the disease and their loved ones.

Moving forward, the researchers plan to conduct a randomized clinical trial to compare the effectiveness of this combination therapy with other available treatments. There is still much work to be done, but this study marks a significant step forward.


Watch the video in which we share some more details about glioblastoma: 
​


    What are your comments about this new research? 

Submit

If you would like to read the research article: 
​


References: 
  1. Nassiri, F., Patil, V., Yefet, L.S. et al. Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial. Nat Med (2023). https://www.nature.com/articles/s41591-023-02347-y (accessed May 16, 2023)
  2. Scientists find new way to treat deadly brain cancer effectively. Knowrigde. https://knowridge.com/2023/05/scientists-find-new-way-to-treat-deadly-brain-cancer-effectively (accessed May 16, 2023)

You might also like to watch these videos:




Do you need help with cancer diagnosis?

Please fill the application form on our CERI Personalized Patient Program page - we CAN help you!

#Empowermentagainstcancer™ #CERICancerEducation #CERICares

#cancer #glioblastoma #gbm #clinicaltrial #immunotherapy #chemotherapy #cancerfree #eradicatingcancer #metastaticcancer #cancereducation #cancerresearch #cancertreatment #canceredinstitute

GET YOUR FREE ARTICLE: Make sure to get your free article as our gift to you! Go to: canceredinstitute.org/ceri-simplified-cancer-research-articles

CORONAVIRUS PAGE: For our educational and up-to-date informational page on Coronavirus, go to: canceredinstitute.org/coronavirus

FOLLOW US for DAILY information and updates: 
  • INSTAGRAM: instagram.com/canceredinstitute 
  • FACEBOOK: facebook.com/canceredinstitute 
  • Twitter: twitter.com/canceredinst 
  • LinkedIn: linkedin.com/company/canceredinstitute ​

You might also like:


Disclaimer: We can not assume responsibility of misinterpretation of content.

    Help us to serve you better!

Submit

Please donate to support our program - help us save MORE lives!

Picture
Yes, I'd like to help CERI continue saving lives!

Make a Monthly Contribution

Cancer Education and Research Institute® (formerly Cancer Research Simplified) is an independent 501(c)(3) non-profit organization.
Homepage 
Türkçe
Deutsch

About us
Meet the Founder
Meet the Team

News Room
Media Kit
Press Releases 
Watch Cancer Videos
Kanser videolarını izle
Krebs Videos ansehen
Cancer Resources

CERI Youth Program

Events

Shop at CERI


Ways to Help
Donate
Volunteer
Become A Sponsor

Blog
Blog-Deutsch
Blog-Türkçe
Blog-Afrikaans
Blog-Espanol
Blog-Italiano
Blog-Russkij
Blog-Portugues


Cancer Awareness Months



Stay Involved
Facebook
Twitter
Youtube
LinkedIn

Testimonials

Jobs

Contact Us
Cancer Research Simplified Homepage
Terms of Service
Privacy Policy
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Copyright © 2013-2023 Cancer Education and Research Institute®. All Rights Reserved. 
Sitemizdeki yazı, video ve resim her hakkı saklıdır. İzinsiz, kaynak gösterilmeden kullanılamaz.  
Alle Rechte vorbehalten.                             

Powered by Cancer Education and Research Institute®